НовостиBenzingaHC Wainwright & Co. Maintains Buy on Bicara Therapeutics, Lowers Price Target to $36 HC Wainwright & Co. Maintains Buy on Bicara Therapeutics, Lowers Price Target to $36 Benzinga 2026.11.11 12:40 (GMT+0) Открыть на Benzinga Другие новости